HIV infection of the nervous system frequently results in neuropsychiatric complications and is a major cause of disability in the HIV infected population. To date there is no effective treatment for the illness and is further complicated by the fact that this infection disproportionately affects racial and ethnic minorities. Several barriers need to be overcome if we want to make a significant impact on this illness. Not only do we need to understand the social and cultural diversities that impact the spread of this infection and our ability to treat these populations, but even the pathophysiological studies and development of treatment strategies need to pay close attention to racial and ethic diversity. Few published studies suggest that host genetic factors may be critical in determining host susceptibility to HIV dementia and as the field of pharmacogenetics is evolving, it is also becoming clear that treatment strategies also need to be tailored based of host genetics. Another major barrier is the lack of scientists from racial and ethnic minority groups in the field of NeuroAIDS research. We have taken several steps to address each of these issues. We have developed a program on the premise that the principal barrier to diversity in science is not a lack of talent, but rather a lack of opportunity. We devised a course in NeuroAIDS that not only uses the state of the art technology and the best teachers and researchers in the field, but the subject content is specifically geared to address each of the issues and point out areas of research that are needed to accomplish these goals. This 12 week course will be webcast so that students will be able to take it from anywhere in the country and yet actively engage in a discussion with the teachers. This didactic course will be followed up with a laboratory based project for a duration of 3-6 months for select students to generate preliminary data for a application focused on neuro-AIDS. To accomplish these goals, we will exploit our existing collaborations with University of Puerto Rico and University of Hawaii to train students and postdoctoral fellows from racial and ethnic minorities. We will also train researchers at Johns Hopkins University in issues that face HIV infected populations of racial and ethnic minorities. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Education Projects (R25)
Project #
5R25MH080661-02
Application #
7407431
Study Section
Special Emphasis Panel (ZMH1-ERB-N (03))
Program Officer
Stoff, David M
Project Start
2007-04-16
Project End
2010-03-31
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
2
Fiscal Year
2008
Total Cost
$186,151
Indirect Cost
Name
Johns Hopkins University
Department
Neurology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Periyasamy, Palsamy; Liao, Ke; Kook, Yeon Hee et al. (2018) Cocaine-Mediated Downregulation of miR-124 Activates Microglia by Targeting KLF4 and TLR4 Signaling. Mol Neurobiol 55:3196-3210
Jimenez-Torres, Gladys J; Wojna, Valerie; Rosario, Ernesto et al. (2017) Assessing health-related resiliency in HIV+ Latin women: Preliminary psychometric findings. PLoS One 12:e0181253
Saylor, Deanna; Dickens, Alex M; Sacktor, Ned et al. (2016) HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol 12:234-48
Singer, Elyse J; Thames, April D (2016) Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment. Neurol Clin 34:33-53
Yang, Lu; Chen, Xufeng; Hu, Guoku et al. (2016) Mechanisms of Platelet-Derived Growth Factor-BB in Restoring HIV Tat-Cocaine-Mediated Impairment of Neuronal Differentiation. Mol Neurobiol 53:6377-6387
Yang, Lu; Yao, Honghong; Chen, Xufeng et al. (2016) Role of Sigma Receptor in Cocaine-Mediated Induction of Glial Fibrillary Acidic Protein: Implications for HAND. Mol Neurobiol 53:1329-42
Hammond, Edward R; Crum, Rosa M; Treisman, Glenn J et al. (2016) Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study. J Neurovirol 22:479-87
Beck, Sarah E; Queen, Suzanne E; Viscidi, Raphael et al. (2016) Central nervous system-specific consequences of simian immunodeficiency virus Gag escape from major histocompatibility complex class I-mediated control. J Neurovirol 22:498-507
Cai, Yu; Arikkath, Jyothi; Yang, Lu et al. (2016) Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders. Autophagy 12:225-44
Beck, Sarah E; Queen, Suzanne E; Witwer, Kenneth W et al. (2015) Paving the path to HIV neurotherapy: Predicting SIV CNS disease. Eur J Pharmacol 759:303-12

Showing the most recent 10 out of 39 publications